LG
Ligand Pharmaceuticals, Inc.
LGNZZ · OTC
$0.07 -7.14% (-$0.01)
1M -14.29%
Market Cap $1.30M
P/E Ratio 0.01x
Div. Yield -
ROE 20.06%
Bulios Fair Price
$0.08
23.1% upside
Trenutna cena
$0.065
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LGNZZ trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
P/E 0.01x
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
100 /100
Strong FCF margin 45.24%
Op. margin 34.45%
Gross margin 90.70%
Quality
49 /100
Average Asset turnover 0.13x
ROA 9.02%
ROIC 3.88%
Debt
81 /100
Low Net debt/EBITDA 0.73x
Int. coverage 51.04x
Debt/Equity 1.16x
Stability
91 /100
Stable Beta 0.98x
EPS volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LGNZZ
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Todd C. Davis
Employees
47
Headquarters
Jupiter
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report